We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Progress Toward Measles Elimination -- Worldwide, 2000-2022.
- Authors
Minta, Anna A.; Ferrari, Matt; Antoni, Sebastien; Portnoy, Allison; Sbarra, Alyssa; Lambert, Brian; Hatcher, Cynthia; Hsu, Christopher H.; Lee Lee Ho; Steulet, Claudia; Gacic-Dobo, Marta; Rota, Paul A.; Mulders, Mick N.; Bose, Anindya Sekhar; Caro, William Perea; O'Connor, Patrick; Crowcroft, Natasha S.
- Abstract
Measles is a highly contagious, vaccine-preventable disease that requires high population immunity for transmission to be interrupted. All six World Health Organization regions have committed to eliminating measles; however, no region has achieved and sustained measles elimination. This report describes measles elimination progress during 2000-2022. During 2000-2019, estimated coverage worldwide with the first dose of measles-containing vaccine (MCV) increased from 72% to 86%, then declined to 81% in 2021 during the COVID-19 pandemic, representing the lowest coverage since 2008. In 2022, first-dose MCV coverage increased to 83%. Only one half (72) of 144 countries reporting measles cases achieved the measles surveillance indicator target of two or more discarded cases per 100,000 population in 2022. During 2021-2022, estimated measles cases increased 18%, from 7,802,000 to 9,232,300, and the number of countries experiencing large or disruptive outbreaks increased from 22 to 37. Estimated measles deaths increased 43% during 2021-2022, from 95,000 to 136,200. Nonetheless, an estimated 57 million measles deaths were averted by vaccination during 2000-2022. In 2022, measles vaccination coverage and global surveillance showed some recovery from the COVID-19 pandemic setbacks; however, coverage declined in low-income countries, and globally, years of suboptimal immunization coverage left millions of children unprotected. Urgent reversal of coverage setbacks experienced during the COVID-19 pandemic can be accomplished by renewing efforts to vaccinate all children with 2 MCV doses and strengthening surveillance, thereby preventing outbreaks and accelerating progress toward measles elimination.
- Subjects
MEASLES vaccines; COVID-19 pandemic; VACCINATION of children; EPIDEMICS; MEDICAL statistics
- Publication
MMWR: Morbidity & Mortality Weekly Report, 2023, Vol 72, Issue 46, p1262
- ISSN
0149-2195
- Publication type
Article
- DOI
10.15585/mmwr.mm7246a3